drugset / Trial / NCT01476332
Safety, Tolerability and Pharmacokinetics of 0.5% and 2.5% Cis-UCA Eye Drops in Adult Healthy Volunteers (Phase I)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this two-part study is to evaluate safety, tolerability and pharmacokinetics of 0.5% and 2.5% cis-UCA eye drops in comparison to placebo in adult healthy volunteers.
Timeline
- Start
- 2011-11
- Primary completion
- 2012-03
- Completion
- 2012-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | cis-urocanic acid | Small molecule | 0.5 % | Topical |
| Subject | cis-urocanic acid | Small molecule | 2.5 % | Topical |